Liraglutide Audit ADA Chicago 2013 - Poster

Does Liraglutide Therapy Affect the Metabolic Response in Patients with An Elevated Alanine Aminotransferase and Type 2 Diabetes Mellitus?: The Association of British Clinical Diabetologists (ABCD) Nationwide Liraglutide Audit

Sen Gupta P1, Thong KY1, Armstrong M2, Newsome PN2, Winocour P3, Ryder REJ1

1City Hospital, Birmingham, UK

2University of Birmingham, Birmingham, UK

3Queen Elizabeth Hospital, Welwyn Garden City, UK

Discipline

Diabetes
Resource taxonomy
Audit Posters
Clinical taxonomy
Treatments for diabetes Type 2 diabetes mellitus
Listing status
Archived

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • A. Menarini Diagnostics
  • Advanced Therapeutics (UK) Ltd
  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Bronze

  • Roche Diabetes Care

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd